CTOs on the Move

Insulet

www.insulet.com

 
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. ...
  • Number of Employees: 250-1000
  • Annual Revenue: $500M-1 Billion
  • www.insulet.com
  • 600 Technology Park Drive Ste 200
    Billerica, MA USA 01821
  • Phone: 978.600.7000

Executives

Name Title Contact Details
Eric Benjamin
 Chief Operating Officer Profile
Cristian Pimentel
 Sr. Director, Product Security Profile
Mark Field
 Group Vice President and Chief Technology Officer Profile
Jacob Combs
 Senior Director of Medical Device Security Profile
Pavan Mutnuri
 Senior Director Information Technology Governance, Risk and Compliance Profile

Similar Companies

Sovereign Medical Service

Sovereign Medical Services (SMS “The Company” is a leader in the fast-growing Medical Ancillary Services within the health care industry. SMS provides the health care professional: management expertise, and investment opportunities in multiple Medical Surgical services. It also provides expertise in managing primary care and multi-specialty practices, with the State of Art information technology systems. These ancillaries are high quality, profitable, cost effective services.

Potrero Medical

Potrero Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence.

GenMark Diagnostics

In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the Board. In 2009, a collaboration between Dr. Kayyem and Christopher Gleeson began. The two redefined the company strategy, and brought in a new board of directors, executive leadership team, and commercial management. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. Mr. Gleeson remained an integral part of GenMark`s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. Dr. Kayyem currently serves as SVP, Research and Development.

Bioanalytical Instruments

Bioanalytical Instruments is a Carolina, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Intrinsic Therapuetics

Intrinsic Therapuetics is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.